Shanghai Pharma Announces New Board Structure
Company Announcements

Shanghai Pharma Announces New Board Structure

Shanghai Pharmaceuticals Holding Co (HK:2607) has released an update.

Shanghai Pharmaceuticals Holding Co., Ltd. has confirmed the composition of its board of directors and various committees as of 27 May 2024, including executive and independent non-executive members. Key positions announced include Mr. YANG Qiuhua as Chairman and convener of the Strategy Committee, alongside the formation of Nomination, Audit, and Remuneration and Assessment Committees with their respective conveners.

For further insights into HK:2607 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskShanghai Pharmaceuticals Renews Key Procurement Agreement
TipRanks HongKong Auto-Generated NewsdeskShanghai Pharmaceuticals Joins New Biomedicine Venture Fund
TipRanks HongKong Auto-Generated NewsdeskShanghai Pharmaceuticals to Announce Q3 Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App